Allweiss L. Strong intrahepatic decline of hepatitis D virus RNA and antigen after 24 weeks of treatment with Myrcludex B in combination with Tenofovir in chronic HBV/HDV infected patients: Interim results from a multicenter, open-label phase 2b clinical trial. PS-162.
Een op de 10 ervaart ≥ 10% gewichtstoename na switch naar TAF of INSTI
sep 2022 | HIV, Virale infecties